Inotuzumab Ozogamicin Injection

225 interactions 104 cited references

Also sold as: Besponsa Besponsa®

About Inotuzumab Ozogamicin Injection

Inotuzumab ozogamicin injection is used to treat certain acute lymphoblastic leukemia (ALL; a type of cancer that begins in the white blood cells) in adults who have not responded to previous cancer treatments. Inotuzumab ozogamicin injection is in a class of medications called monoclonal antibodies. It works by activa… Read the full Inotuzumab Ozogamicin Injection drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Pimozide Piperaquine Rubella Virus Vaccine, Live Saquinavir Smallpox Monkeypox Vaccine Sparfloxacin

21 Contraindicated 204 Major

All (225) Contraindicated (21) Major (204)

Major

Inotuzumab Ozogamicin Injection Levofloxacin Levaquin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Lofexidine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Lonafarnib Zokinvy An increased risk of QT interval prolongation and torsade de pointes Details Inotuzumab Ozogamicin Injection Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Inotuzumab Ozogamicin Injection Lumefantrine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Macimorelin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Mavorixafor Xolremdi An increased risk of QT interval prolongation and torsade de pointes Details Inotuzumab Ozogamicin Injection Mefloquine Lariam® Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Methadone Diskets Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Methotrimeprazine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Metronidazole Flagyl Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Mifepristone Korlym Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Milsaperidone An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Mirtazapine Mirataz Increased risk of QT interval prolongation and torsades de pointes Details Inotuzumab Ozogamicin Injection Mizolastine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Mobocertinib Exkivity An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Moricizine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Moxifloxacin Avelox Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Nafarelin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Nelfinavir Viracept Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Nilotinib Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Norfloxacin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Octreotide Bynfezia Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Ofloxacin Floxin® Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Olanzapine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Olodaterol Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Inotuzumab Ozogamicin Injection Ondansetron Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Osilodrostat Isturisa Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Osimertinib Tagrisso Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Oxaliplatin Increased risk of QT-interval prolongation Details Inotuzumab Ozogamicin Injection Ozanimod Additive effects on heart rate Details Inotuzumab Ozogamicin Injection Pacritinib Vonjo® An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Paliperidone Erzofri Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Panobinostat Farydak Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Papaverine Pavacot® Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Paroxetine Paxil Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Pasireotide Signifor Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Pazopanib Votrient Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Pentamidine NebuPent Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Perphenazine Increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.